|
Recent Material Events for Haemonetics Corporation
|
| Date |
Description |
|
Oct 29, 2012
|
On October 29, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the second quarter ended September 29, 2012. A copy of the release is furnished with this report as exhibit 99.1.
|
|
Oct 29, 2012
|
On October 29, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the second quarter ended September 29, 2012. A copy of the release is furnished with this report as exhibit 99.1.
|
|
Oct 09, 2012
|
The Company is furnishing herewith as Exhibit 99.1 the following Unaudited Pro Forma Condensed Combined Financial Information prepared to give effect to the Company's acquisition of the whole blood business. The pro forma financial statements include
|
|
Sep 27, 2012
|
On September 17, 2012, Haemonetics Corporation issued a press release regarding the Hemerus Medical, LLC acquisition. The press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.
|
|
Aug 07, 2012
|
On August 1, 2012, we completed the acquisition from Pall Corporation (“Pall”) of substantially all of the assets relating to its blood collection, filtration, processing, storage and re-infusion product lines, and all of the outstanding
|
|
Aug 07, 2012
|
On August 1, 2012, we completed the acquisition from Pall Corporation (“Pall”) of substantially all of the assets relating to its blood collection, filtration, processing, storage and re-infusion product lines, and all of the outstanding
|
|
Aug 02, 2012
|
On August 1, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the first quarter ended June 30, 2012. A copy of the release is furnished with this report as exhibit 99.1.
|
|
Aug 02, 2012
|
On August 1, 2012, Haemonetics Corporation (the “Company”) issued a press release announcing financial results for the first quarter ended June 30, 2012. A copy of the release is furnished with this report as exhibit 99.1.
|
|
Aug 02, 2012
|
On July 27, 2012, the Board of Directors of Haemonetics Corporation (the “Company”) adopted the Haemonetics Corporation Non-Qualified Deferred Compensation Plan (the “Plan”). The Plan is a nonqualified deferred compensation pl
|
|
May 22, 2012
|
Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
|
